All data from the Kaplan–Meier plotter dataset of this part demonstrated that MYL5 could be a potential and poor prognostic factor for lung cancer and gastric cancer patients, but a better prognostic biomarker for breast cancer and ovarian cancer patients. This evidence concerns the gene MYL5 and ovarian carcinoma.